- Home
- HLIO vs ATRC Comparison
HLIO vs ATRC Comparison
Compare HLIO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLIO
- ATRC
- Stock Information
- Founded
- HLIO 1970
- ATRC 2000
- Country
- HLIO United States
- ATRC United States
- Employees
- HLIO N/A
- ATRC N/A
- Industry
- HLIO Metal Fabrications
- ATRC Medical/Dental Instruments
- Sector
- HLIO Industrials
- ATRC Health Care
- Exchange
- HLIO Nasdaq
- ATRC Nasdaq
- Market Cap
- HLIO 1.8B
- ATRC 1.7B
- IPO Year
- HLIO N/A
- ATRC 2005
- Fundamental
- Price
- HLIO $56.86
- ATRC $33.98
- Analyst Decision
- HLIO Strong Buy
- ATRC Strong Buy
- Analyst Count
- HLIO 5
- ATRC 9
- Target Price
- HLIO $47.60
- ATRC $52.00
- AVG Volume (30 Days)
- HLIO 296.5K
- ATRC 510.4K
- Earning Date
- HLIO 11-03-2025
- ATRC 10-29-2025
- Dividend Yield
- HLIO 0.63%
- ATRC N/A
- EPS Growth
- HLIO 17.55
- ATRC N/A
- EPS
- HLIO 1.05
- ATRC N/A
- Revenue
- HLIO $782,000,000.00
- ATRC $518,304,999.00
- Revenue This Year
- HLIO $3.85
- ATRC $16.32
- Revenue Next Year
- HLIO $2.60
- ATRC $12.37
- P/E Ratio
- HLIO $54.12
- ATRC N/A
- Revenue Growth
- HLIO N/A
- ATRC 15.80
- 52 Week Low
- HLIO $24.76
- ATRC $28.29
- 52 Week High
- HLIO $58.52
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- HLIO 59.98
- ATRC 38.43
- Support Level
- HLIO $56.11
- ATRC $30.94
- Resistance Level
- HLIO $58.52
- ATRC $37.28
- Average True Range (ATR)
- HLIO 2.15
- ATRC 1.69
- MACD
- HLIO 0.22
- ATRC -0.34
- Stochastic Oscillator
- HLIO 81.24
- ATRC 40.68
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.